跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LYDOCAN INJECTION 2% - HSA Drug Approval Details
Approvals
/
HSA
/
LYDOCAN INJECTION 2%
Approved
THERAPEUTIC
LYDOCAN INJECTION 2%
Y.S.P. INDUSTRIES (M) SDN. BHD. (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 1, 2018
Approval ID
b5a49136bf504be4
Company
Y.S.P. INDUSTRIES (M) SDN. BHD. (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
b5a49136bf504be4
Drug Name
LYDOCAN INJECTION 2%
Product Name
LYDOCAN INJECTION 2%
Approval Number
SIN15519P
Approval Date
2018-08-01
Registrant
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Licence Holder
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION
Route Of Administration
SUBCUTANEOUS
Atc Code
N01BB02
Atc Item Name
lidocaine
Pharma Manufacturer Name
YUNG SHIN PHARMACEUTICAL (SINGAPORE) PTE LTD
Company Detail Path
/organization/yung-shin-pharmaceutical-singapore-pte-ltd
Active Ingredients
Lidocaine Hydrochloride
200mg/10ml
LIDOCAINE HYDROCHLORIDE
200 MG/10 ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 1, 2018
Approval ID
b5a49136bf504be4
Type
Therapeutic
Back to HSA Approvals